Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma

Individually, tissue and soluble markers involved in the programmed cell death protein 1/programmed death‐ligand (PD‐1/PD‐L) axis have been described as biomarkers with clinical value in classical Hodgkin lymphoma (cHL). In the context of the success of immune checkpoint blockade therapy in cHL, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Veldman, Johanna, Alsada, Zainab N. D., van den Berg, Anke, Plattel, Wouter J., Diepstra, Arjan, Visser, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematological Malignancy – Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247981/
https://www.ncbi.nlm.nih.gov/pubmed/33620088
http://dx.doi.org/10.1111/bjh.17362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247981/
https://www.ncbi.nlm.nih.gov/pubmed/33620088
http://dx.doi.org/10.1111/bjh.17362

Ejemplares similares